Transforming growth factor-beta and matrix metalloproteinases: Functional interactions in tumor stroma-infiltrating myeloid cells

The Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Krstic, Jelena ^a   Santibanez, Juan F ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA; TUMOR PROTEIN;

ANIMAL; BIOSYNTHESIS; BONE MARROW CELL; CELL COMMUNICATION; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; STROMA CELL; TUMOR MICROENVIRONMENT;

ANIMALS; CELL COMMUNICATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; METALLOPROTEASES; MYELOID CELLS; NEOPLASM PROTEINS; NEOPLASMS; STROMAL CELLS; TRANSFORMING GROWTH FACTOR BETA; TUMOR MICROENVIRONMENT;

EID: 84893858450     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2014/521754     Document Type: Review

References (139)

1. Santibañez J. F., Quintanilla M., Bernabeu C., TGF- β /TGF- β receptor system and its role in physiological and pathological conditions. Clinical Science 2011 121 6 233 251 2-s2.0-79961139550 10.1042/CS20110086
2. Bierie B., Moses H. L., TGF- β and cancer. Cytokine and Growth Factor Reviews 2006 17 1-2 29 40 2-s2.0-30944432734 10.1016/j.cytogfr.2005.09. 006 (Pubitemid 43117514)
3. Padua D., Massagué M., Roles of TGFbeta in metastasis. Cell Research 2009 19 1 89 102
4. Quintanilla M., del Castillo G., Kocic J., Santibanez J. F., Oshiro N., Miyagi E., TGF-B and MMPs: a complex regulatory loop involved in tumor progression. Matrix Metalloproteinases: Biology, Functions and Clinical Implications 2012 Nova Science
5. Stover D. G., Bierie B., Moses H. L., A delicate balance: TGF- β and the tumor microenvironment. Journal of Cellular Biochemistry 2007 101 4 851 861 2-s2.0-34447261691 10.1002/jcb.21149 (Pubitemid 47040867)
6. Wakefield L. M., Roberts A. B., TGF- β signaling: positive and negative effects on tumorigenesis. Current Opinion in Genetics and Development 2002 12 1 22 29 2-s2.0-0036467496 10.1016/S0959-437X(01)00259-3 (Pubitemid 34094985)
7. Hua H., Li M., Luo T., Yin Y., Jiang Y., Matrix metalloproteinases in tumorigenesis: an evolving paradigm. Cellular and Molecular Life Sciences 2011 68 23 3853 3868 2-s2.0-82255186386 10.1007/s00018-011-0763-x
8. Amǎlinei C., Cǎruntu I. D., Giuşcǎ S. E., Bǎlan R. A., Matrix metalloproteinases involvement in pathologic condition. Romanian Journal of Morphology and Embryology 2010 51 2 215 228
9. Egeblad M., Werb Z., New functions for the matrix metalloproteinases in cancer progression. Nature Reviews Cancer 2002 2 3 161 174 2-s2.0-0036512208 (Pubitemid 37328786)
10. Kessenbrock K., Plaks V., Werb Z., Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010 141 1 52 67 2-s2.0-77950931419 10.1016/j.cell.2010.03.015
11. Attisano L., Wrana J. L., Signal transduction by the TGF- β superfamily. Science 2002 296 5573 1646 1647 2-s2.0-0037204990 10.1126/science.1071809 (Pubitemid 34579152)
12. Shi Y., Massagué J., Mechanisms of TGF- β signaling from cell membrane to the nucleus. Cell 2003 113 6 685 700 2-s2.0-0038682002 10.1016/S0092-8674(03)00432-X (Pubitemid 36724933)
13. Itoh S., ten Dijke P., Negative regulation of TGF- β receptor/Smad signal transduction. Current Opinion in Cell Biology 2007 19 2 176 184 2-s2.0-33847716712 10.1016/j.ceb.2007.02.015 (Pubitemid 46386411)
14. Santibanez J. F., Kocic J., Transforming growth factor-beta superfamily, implications in development and differentiation of stem cells. BioMolecular Concepts 2012 5 429 445
15. Mu Y., Gudey S. K., Landström M., Non-Smad signaling pathways. Cell and Tissue Research 2012 347 1 11 20 2-s2.0-84859443358 10.1007/s00441-011-1201- y
16. Gordon K. J., Blobe G. C., Role of transforming growth factor- β superfamily signaling pathways in human disease. Biochimica et Biophysica Acta 2008 1782 4 197 228 2-s2.0-40849133772 10.1016/j.bbadis.2008.01.006
17. Gatalica Z., Torlakovic E., Pathology of the hereditary colorectal carcinoma. Familial Cancer 2008 7 1 15 26 2-s2.0-46449087103 10.1007/s10689-007-9146-8
18. Otten J., Carsten Bokemeyer C., Fiedler W., TGF- β superfamily receptors-targets for antiangiogenic therapy? Journal of Oncology 2010 2010 10 317068 10.1155/2010/317068
19. Howe J. R., Sayed M. G., Ahmed A. F., Ringold J., Larsen-Haidle J., Merg A., Mitros F. A., Vaccaro C. A., Petersen G. M., Giardiello F. M., Tinley S. T., Aaltonen L. A., Lynch H. T., The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations. Journal of Medical Genetics 2004 41 7 484 491 2-s2.0-3142746721 (Pubitemid 38932108)
20. Sweet K., Willis J., Zhou X.-P., Gallione C., Sawada T., Alhopuro P., Khoo S. K., Patocs A., Martin C., Bridgeman S., Heinz J., Pilarski R., Lehtonen R., Prior T. W., Frebourg T., Teh B. T., Marchuk D. A., Aaltonen L. A., Eng C., Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis. Journal of the American Medical Association 2005 294 19 2465 2473 2-s2.0-27744511296 10.1001/jama.294.19.2465 (Pubitemid 41627924)
21. Shin K.-H., Park Y. J., Park J.-G., Mutational analysis of the transforming growth factor β receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients. Clinical Cancer Research 2000 6 2 536 540 2-s2.0-0343415643 (Pubitemid 30111476)
22. Millet C., Zhang Y. E., Roles of Smad3 in TGF- β signaling during carcinogenesis. Critical Reviews in Eukaryotic Gene Expression 2007 17 4 281 293 2-s2.0-34347331057 (Pubitemid 47015558)
23. Baldwin R. L., Friess H., Yokoyama M., Attenuated ALK5 receptor expression in human pancreatic cancer: correlation with resistance to growth inhibition. International Journal of Cancer 1996 67 2 283 288 10.1002/(SICI)1097-0215(19960717)67:2LTHEXA283::AID-IJC21>3.0.CO;2-B (Pubitemid 26274162)
24. Hinshelwood R. A., Huschtscha L. I., Melki J., Stirzaker C., Abdipranoto A., Vissel B., Ravasi T., Wells C. A., Hume D. A., Reddel R. R., Clark S. J., Concordant epigenetic silencing of transforming growth factor- β signaling pathway genes occurs early in breast carcinogenesis. Cancer Research 2007 67 24 11517 11527 2-s2.0-37549060948 10.1158/0008-5472.CAN-07-1284
25. Izumoto S., Arita N., Ohnishi T., Hiraga S., Taki T., Tomita N., Ohue M., Hayakawa T., Microsatellite instability and mutated type II transforming growth factor- β receptor gene in gliomas. Cancer Letters 1997 112 2 251 256 2-s2.0-0031590968 10.1016/S0304-3835(96)04583-1 (Pubitemid 27104303)
26. Luwor R. B., Kaye A. H., Zhu H.-J., Transforming growth factor-beta (TGF- β) and brain tumours. Journal of Clinical Neuroscience 2008 15 8 845 855 2-s2.0-45849110280 10.1016/j.jocn.2008.01.003
27. Gialeli C., Theocharis A. D., Karamanos N. K., Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. The FEBS Journal 2011 278 1 16 27 2-s2.0-78650424066 10.1111/j.1742-4658.2010. 07919.x
28. Löffek S., Schilling O., Franzke C.-W., Series "matrix metalloproteinases in lung health and disease": biological role of matrix metalloproteinases: a critical balance. European Respiratory Journal 2011 38 1 191 208 2-s2.0-79960153872 10.1183/09031936.00146510
29. Murphy G., Tissue inhibitors of metalloproteinases. Genome Biology 2011 12 11, article 233 10.1186/gb-2011-12-11-233
30. López-Otín C., Matrisian L. M., Emerging roles of proteases in tumour suppression. Nature Reviews Cancer 2007 7 10 800 808 2-s2.0-34648815810 10.1038/nrc2228 (Pubitemid 47463671)
31. Annes J. P., Munger J. S., Rifkin D. B., Making sense of latent TGF β activation. Journal of Cell Science 2003 116 2 217 224 2-s2.0-0037439630 10.1242/jcs.00229 (Pubitemid 36163863)
32. Yu Q., Stamenkovic I., Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF- β and promotes tumor invasion and angiogenesis. Genes and Development 2000 14 2 163 176 2-s2.0-0034650486 (Pubitemid 30070982)
33. Mu D., Cambier S., Fjellbirkeland L., Baron J. L., Munger J. S., Kawakatsu H., Sheppard D., Courtney Broaddus V., Nishimura S. L., The integrin α β 8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF- β 1. Journal of Cell Biology 2002 157 3 493 507 2-s2.0-0037192933 10.1083/jcb.200109100 (Pubitemid 34839812)
34. Kerr L. D., Miller D. B., Matrisian L. M., TGF- β 1 inhibition of transin/stromelysin gene expression is mediated through a fos binding sequence. Cell 1990 61 2 267 278 2-s2.0-0025344028 10.1016/0092-8674(90)90807-Q (Pubitemid 20149358)
35. Narayan S., Thangasamy T., Balusu R., Transforming growth factor -beta receptor signaling in cancer. Frontiers in Bioscience 2005 10 1135 1145 2-s2.0-33044503641
36. Zawel L., Le Dai J., Buckhaults P., Zhou S., Kinzler K. W., Vogelstein B., Kern S. E., Human Smad3 and Smad4 are sequence-specific transcription activators. Molecular Cell 1998 1 4 611 617 2-s2.0-0032014216 (Pubitemid 128374697)
37. Hijova E., Matrix metalloproteinases: their biological functions and clinical implications. Bratislavske Lekarske Listy 2005 106 3 127 132 2-s2.0-27244459614
38. Lin C.-S., Pan C.-H., Regulatory mechanisms of atrial fibrotic remodeling in atrial fibrillation. Cellular and Molecular Life Sciences 2008 65 10 1489 1508 2-s2.0-44449120187 10.1007/s00018-008-7408-8
39. White L. A., Mitchell T. I., Brinckerhoff C. E., Transforming growth factor β inhibitory element in the rabbit matrix metalloproteinase-1 (collagenase-1) gene functions as a repressor of constitutive transcription. Biochimica et Biophysica Acta 2000 1490 3 259 268 2-s2.0-0033953612 10.1016/S0167-4781(00)00002-6 (Pubitemid 30103799)
40. Yuan W., Varga J., Transforming growth factor- β repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3. Journal of Biological Chemistry 2001 276 42 38502 38510 2-s2.0-0035914339 10.1074/jbc.M107081200
41. Gaire M., Magbanua Z., McDonnell S., McNeil L., Lovett D. H., Matrisian L. M., Structure and expression of the human gene for the matrix metalloproteinase matrilysin. Journal of Biological Chemistry 1994 269 3 2032 2040 2-s2.0-0028158488 (Pubitemid 24035410)
42. Ogawa K., Chen F., Kuang C., Chen Y., Suppression of matrix metalloproteinase-9 transcription by transforming growth factor- β is mediated by a nuclear factor- B site. The Biochemical Journal 2004 381 2 413 422 2-s2.0-3242758083 10.1042/BJ20040058 (Pubitemid 38969685)
43. Tardif G., Reboul P., Dupuis M., Geng C., Duval N., Pelletier J.-P., Martel-Pelletier J., Transforming growth factor- β induced collagenase-3 production in human osteoarthritic chondrocytes is triggered by smad proteins: cooperation between activator protein-1 and PEA-3 binding sites. Journal of Rheumatology 2001 28 7 1631 1639 2-s2.0-0034943365 (Pubitemid 32660638)
44. Lohi J., Lehti K., Valtanen H., Parks W. C., Keski-Oja J., Structural analysis and promoter characterization of the human membrane-type matrix metalloproteinase-1 (MT1-MMP) gene. Gene 2000 242 1-2 75 86 2-s2.0-0033973613 10.1016/S0378-1119(99)00549-1 (Pubitemid 30065091)
45. Ishikawa F., Miyoshi H., Nose K., Shibanuma M., Transcriptional induction of MMP-10 by TGF- Β mediated by activation of MEF2A and downregulation of class IIa HDACs. Oncogene 2010 29 6 909 919 2-s2.0-76849086904 10.1038/onc.2009.387
46. Liberati N. T., Datto M. B., Frederick J. P., Shen X., Wong C., Rougier-Chapman E. M., Wang X.-F., Smads bind directly to the Jun family of AP-1 transcription factors. Proceedings of the National Academy of Sciences of the United States of America 1999 96 9 4844 4849 2-s2.0-0033609060 10.1073/pnas.96.9.4844 (Pubitemid 29214499)
47. Verrecchia F., Vindevoghel L., Lechleider R. J., Uitto J., Roberts A. B., Mauviel A., Smad3/AP-1 interactions control transcriptional responses to TGF- β in a promoter-specific manner. Oncogene 2001 20 26 3332 3340 2-s2.0-0035821745 10.1038/sj.onc.1204448 (Pubitemid 32588981)
48. Selvamurugan N., Kwok S., Partridge N. C., Smad3 interacts with JunB and Cbfa1/Runx2 for transforming growth factor- β 1-stimulated collagenase-3 expression in human breast cancer cells. Journal of Biological Chemistry 2004 279 26 27764 27773 2-s2.0-3042549099 10.1074/jbc.M312870200 (Pubitemid 38812618)
49. Fini M. E., Cook J. R., Mohan R., Brinckerhoff C. E., Parks W. C., Mecham R. P., Regulation of matrix metalloproteinase gene expression. Matrix Metalloproteinases 1988 New York, NY, USA Academic Press 299 359
50. Yan C., Boyd D. D., Regulation of matrix metalloproteinase expression expression. Journal of Cellular Physiology 2007 211 1 19 26 2-s2.0-33847683870 10.1002/jcp.20948 (Pubitemid 46363892)
51. Mauviel A., Chung K.-Y., Agarwal A., Tamai K., Uitto J., Cell-specific induction of distinct oncogenes of the jun family is responsible for differential regulation of collagenase gene expression by transforming growth factor- β in fibroblasts and keratinocytes. Journal of Biological Chemistry 1996 271 18 10917 10923 2-s2.0-0029916877 10.1074/jbc.271.18.10917 (Pubitemid 26145831)
52. Kim E.-S., Sohn Y.-W., Moon A., TGF- β -induced transcriptional activation of MMP-2 is mediated by activating transcription factor (ATF)2 in human breast epithelial cells. Cancer Letters 2007 252 1 147 156 2-s2.0-34248401646 10.1016/j.canlet.2006.12.016 (Pubitemid 46738609)
53. Sano Y., Harada J., Tashiro S., Gotoh-Mandeville R., Maekawa T., Ishii S., ATF-2 is a common nuclear target of smad and TAK1 pathways in transforming growth factor- β signaling. Journal of Biological Chemistry 1999 274 13 8949 8957 2-s2.0-0033605562 10.1074/jbc.274.13.8949 (Pubitemid 29164697)
54. Binker M. G., Binker-Cosen A. A., Gaisano H. Y., de Cosen R. H., Cosen-Binker L. I., TGF- β 1 increases invasiveness of SW1990 cells through Rac1/ROS/NF- B/IL-6/MMP-2. Biochemical and Biophysical Research Communications 2011 405 1 140 145 2-s2.0-79551475611 10.1016/j.bbrc.2011.01.023
55. F. Santibanez J., Guerrero J., Quintanilla M., Fabra A., Martínez J., Transforming growth factor- β 1 modulates matrix metalloproteinase-9 production through the Ras/MAPK signaling pathway in transformed keratinocytes. Biochemical and Biophysical Research Communications 2002 296 2 267 273 2-s2.0-0036386902 10.1016/S0006-291X(02)00864-1
56. Tobar N., Villar V., Santibanez J. F., ROS-NF Β mediates TGF- β 1-induced expression of urokinase-type plasminogen activator, matrix metalloproteinase-9 and cell invasion. Molecular and Cellular Biochemistry 2010 340 1-2 195 202 2-s2.0-77954428063 10.1007/s11010-010-0418-5
57. Safina A., Vandette E., Bakin A. V., ALK5 promotes tumor angiogenesis by upregulating matrix metalloproteinase-9 in tumor cells. Oncogene 2007 26 17 2407 2422 2-s2.0-34247100316 10.1038/sj.onc.1210046 (Pubitemid 46597273)
58. Arsura M., Panta G. R., Bilyeu J. D., Cavin L. G., Sovak M. A., Oliver A. A., Factor V., Heuchel R., Mercurio F., Thorgeirsson S. S., Sonenshein G. E., Transient activation of NF- B through a TAK1/IKK kinase pathway by TGF- β 1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation. Oncogene 2003 22 3 412 425 2-s2.0-0037461958 10.1038/sj.onc.1206132 (Pubitemid 36194337)
59. Safina A., Ren M.-Q., Vandette E., Bakin A. V., TAK1 is required for TGF- β 1-mediated regulation of matrix metalloproteinase-9 and metastasis. Oncogene 2008 27 9 1198 1207 2-s2.0-39749195549 10.1038/sj.onc.1210768 (Pubitemid 351294699)
60. Bremnes R. M., Dønnem T., Al-Saad S., Al-Shibli K., Andersen S., Sirera R., Camps C., Marinez I., Busund L.-T., The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer. Journal of Thoracic Oncology 2011 6 1 209 217 2-s2.0-78651073833 10.1097/JTO.0b013e3181f8a1bd
61. Liotta L. A., Kohn E. C., The microenvironment of the tumour: host interface. Nature 2001 411 6835 375 379 2-s2.0-0035902141 10.1038/35077241 (Pubitemid 32467047)
62. Park C. C., Bissell M. J., Barcellos-Hoff M. H., The influence of the microenvironment on the malignant phenotype. Molecular Medicine Today 2000 6 8 324 329 2-s2.0-0034254445 10.1016/S1357-4310(00)01756-1 (Pubitemid 30619340)
63. Ansell S. M., Vonderheide R. H., Cellular composition of the tumor microenvironment. American Society of Clinical Oncology Educational Book 2013 2013 91 97
64. Hu M., Polyak K., Microenvironmental regulation of cancer development. Current Opinion in Genetics and Development 2008 18 1 27 34 2-s2.0-43649085395 10.1016/j.gde.2007.12.006 (Pubitemid 351694443)
65. Noël A., Jost M., Maquoi E., Matrix metalloproteinases at cancer tumor-host interface. Seminars in Cell and Developmental Biology 2008 19 1 52 60 2-s2.0-36849080314 10.1016/j.semcdb.2007.05.011 (Pubitemid 350235981)
66. Han G., Li F., Singh T. P., The pro-inflammatory role of TGF β 1: a paradox? International Journal of Biological Sciences 2012 8 2 228 235
67. Dvorak H. F., Tumors: wounds that do not heal: similarities between tumor stroma generation and wound healing. The New England Journal of Medicine 1986 315 26 1650 1659 2-s2.0-0022891340 (Pubitemid 17052899)
68. Whiteside T. L., The tumor microenvironment and its role in promoting tumor growth. Oncogene 2008 27 45 5904 5912 2-s2.0-53549102755 10.1038/onc.2008.271
69. Allavena P., Garlanda C., Borrello M. G., Sica A., Mantovani A., Pathways connecting inflammation and cancer. Current Opinion in Genetics and Development 2008 18 1 3 10 2-s2.0-43749091281 10.1016/j.gde.2008.01.003 (Pubitemid 351694444)
70. Balkwill F., Charles K. A., Mantovani A., Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005 7 3 211 217 2-s2.0-17644394616 10.1016/j.ccr.2005.02.013 (Pubitemid 40568680)
71. Allavena P., Sica A., Solinas G., Porta C., Mantovani A., The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Critical Reviews in Oncology/Hematology 2008 66 1 1 9 2-s2.0-40049088602 10.1016/j.critrevonc.2007.07.004 (Pubitemid 351324128)
72. Yoshimura A., Wakabayashi Y., Mori T., Cellular and molecular basis for the regulation of inflammation by TGF- β Journal of Biochemistry 2010 147 6 781 792 2-s2.0-77953695161 10.1093/jb/mvq043
73. Manicone A. M., McGuire J. K., Matrix metalloproteinases as modulators of inflammation. Seminars in Cell and Developmental Biology 2008 19 1 34 41 2-s2.0-36849094431 10.1016/j.semcdb.2007.07.003 (Pubitemid 350235986)
74. Ueha S., Shand F. H. W., Matsushima K., Myeloid cell population dynamics in healthy and tumor-bearing mice. International Immunopharmacology 2011 11 7 783 788 2-s2.0-79958068139 10.1016/j.intimp.2011.03.003
75. Kennedy A. D., DeLeo F. R., Neutrophil apoptosis and the resolution of infection. Immunologic Research 2009 43 1-3 25 61
76. Soehnlein O., Weber C., Lindbom L., Neutrophil granule proteins tune monocytic cell function. Trends in Immunology 2009 30 11 538 546 2-s2.0-70350005378 10.1016/j.it.2009.06.006
77. Bingle L., Brown N. J., Lewis C. E., The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. Journal of Pathology 2002 196 3 254 265 2-s2.0-0036187615 10.1002/path.1027 (Pubitemid 34189413)
78. Zumsteg A., Christofori G., Corrupt policemen: inflammatory cells promote tumor angiogenesis. Current Opinion in Oncology 2009 21 1 60 70 2-s2.0-58149267580 10.1097/CCO.0b013e32831bed7e
79. Hagemann T., Wilson J., Burke F., Kulbe H., Li N. F., Plüddemann A., Charles K., Gordon S., Balkwill F. R., Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype. Journal of Immunology 2006 176 8 5023 5032 2-s2.0-33645760428
80. + T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 2009 16 2 91 102 2-s2.0-67651160649 10.1016/j.ccr.2009.06.018
81. Mantovani A., Sozzani S., Locati M., Allavena P., Sica A., Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends in Immunology 2002 23 11 549 555 2-s2.0-0036839143 10.1016/S1471-4906(02)02302-5 (Pubitemid 35223554)
82. Mantovani A., Locati M., Tumor-associated macrophages as a paradigm of macrophage plasticity, diversity, and polarization: lessons and open questions. Arteriosclerosis, Thrombosis, and Vascular Biology 2013 33 7 1478 1483 10.1161/ATVBAHA.113.300168
83. Mantovani A., Sica A., Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Current Opinion in Immunology 2010 22 2 231 237 2-s2.0-77950944395 10.1016/j.coi.2010.01.009
84. Hao N. B., Lü M. H., Fan Y. H., Macrophages in tumor microenvironments and the progression of tumors. Clinical and Developmental Immunology 2012 2012 11 948098 10.1155/2012/948098
85. Obermueller E., Vosseler S., Fusenig N. E., Mueller M. M., Cooperative autocrine and paracrine functions of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the progression of skin carcinoma cells. Cancer Research 2004 64 21 7801 7812 2-s2.0-7444269111 10.1158/0008-5472.CAN-03-3301 (Pubitemid 39446913)
86. Condeelis J., Pollard J. W., Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006 124 2 263 266 2-s2.0-31044433663 10.1016/j.cell.2006.01.007 (Pubitemid 43121975)
87. Wyckoff J., Wang W., Lin E. Y., Wang Y., Pixley F., Stanley E. R., Graf T., Pollard J. W., Segall J., Condeelis J., A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Research 2004 64 19 7022 7029 2-s2.0-4944229701 10.1158/0008-5472.CAN-04-1449 (Pubitemid 39331012)
88. McDonald P. P., Fadok V. A., Bratton D., Henson P. M., Transcriptional and translational regulation of inflammatory mediator production by endogenous TGF- β in macrophages that have ingested apoptotic cells. Journal of Immunology 1999 163 11 6164 6172 2-s2.0-0033485401
89. Giraudo E., Inoue M., Hanahan D., An amino-bisphosphonate targets MMP-9: expressing macrophages and angiogenesis to impair cervical carcinogenesis. Journal of Clinical Investigation 2004 114 5 623 633 2-s2.0-4944239035 10.1172/JCI200422087 (Pubitemid 39578752)
90. Houghton A. M., Grisolano J. L., Baumann M. L., Kobayashi D. K., Hautamaki R. D., Nehring L. C., Cornelius L. A., Shapiro S. D., Macrophage elastase (matrix metalloproteinase-12) suppresses growth of lung metastases. Cancer Research 2006 66 12 6149 6155 2-s2.0-33745700206 10.1158/0008-5472.CAN- 04-0297
91. Feinberg M. W., Jain M. K., Werner F., Sibinga N. E. S., Wiesel P., Wang H., Topper J. N., Perrella M. A., Lee M.-E., Transforming growth factor- β 1 inhibits cytokine-mediated induction of human metalloelastase in macrophages. Journal of Biological Chemistry 2000 275 33 25766 25773 2-s2.0-0034682848 10.1074/jbc.M002664200
92. Jeon S.-H., Chae B.-C., Kim H.-A., Seo G.-Y., Seo D.-W., Chun G.-T., Kim N.-S., Yie S.-W., Byeon W.-H., Eom S.-H., Ha K.-S., Kim Y.-M., Kim P.-H., Mechanisms underlying TGF- β 1-induced expression of VEGF and Flk-1 in mouse macrophages and their implications for angiogenesis. Journal of Leukocyte Biology 2007 81 2 557 566 2-s2.0-33846675282 10.1189/jlb.0806517 (Pubitemid 46198408)
93. Novitskiy S. V., Pickup M. W., Chytil A., Deletion of TGF-beta signaling in myeloid cells enhances their anti-tumorigenic properties. Journal of Leukocyte Biology 2012 92 3 641 651 10.1189/jlb.1211639
94. Welch D. R., Schissel D. J., Howrey R. P., Aeed P. A., Tumor-elicited polymorphonuclear cells, in contrast to 'normal' circulating polymorphonuclear cells, stimulate invasive and metastatic potentials of rat mammary adenocarcinoma cells. Proceedings of the National Academy of Sciences of the United States of America 1989 86 15 5859 5863 2-s2.0-0343381078 (Pubitemid 19217548)
95. Fridlender Z. G., Albelda S. M., Tumor-associated neutrophils: friend or foe? Carcinogenesis 2012 33 5 949 955 2-s2.0-84860484044 10.1093/carcin/bgs123
96. Mantovani A., Cassatella M. A., Costantini C., Jaillon S., Neutrophils in the activation and regulation of innate and adaptive immunity. Nature Reviews Immunology 2011 11 8 519 531 2-s2.0-79960829290 10.1038/nri3024
97. Galdiero M. R., Garlanda C., Jaillon S., Tumor associated macrophages and neutrophils in tumor progression. Journal of Cellular Physiology 2013 228 7 1404 1412 10.1002/jcp.24260
98. Coussens L. M., Tinkle C. L., Hanahan D., Werb Z., MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 2000 103 3 481 490 2-s2.0-0034721666
99. Yang L., DeBusk L. M., Fukuda K., Fingleton B., Green-Jarvis B., Shyr Y., Matrisian L. M., Carbone D. P., Lin P. C., Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell 2004 6 4 409 421 2-s2.0-5444225991 10.1016/j.ccr.2004.08.031 (Pubitemid 39361441)
100. Fridlender Z. G., Sun J., Kim S., Kapoor V., Cheng G., Ling L., Worthen G. S., Albelda S. M., Polarization of tumor-associated neutrophil phenotype by TGF- β: "N1" versus "N2" TAN. Cancer Cell 2009 16 3 183 194 2-s2.0-69249222379 10.1016/j.ccr.2009.06.017
101. Pekarek L. A., Starr B. A., Toledano A. Y., Schreiber H., Inhibition of tumor growth by elimination of granulocytes. Journal of Experimental Medicine 1995 181 1 435 440 2-s2.0-0028928899 10.1084/jem.181.1.435
102. Mantovani A., The Yin-Yang of tumor-associated neutrophils. Cancer Cell 2009 16 3 173 174 2-s2.0-69249242897 10.1016/j.ccr.2009.08.014
103. Chen J.-J., Sun Y., Nabel G. J., Regulation of the proinflammatory effects of Fas ligand (CD95L). Science 1998 282 5394 1714 1717 2-s2.0-0032573581 (Pubitemid 28549288)
104. Acuff H. B., Carter K. J., Fingleton B., Gorden D. L., Matrisian L. M., Matrix metalloproteinase-9 from bone marrow-derived cells contributes to survival but not growth of tumor cells in the lung microenvironment. Cancer Research 2006 66 1 259 266 2-s2.0-31544469201 10.1158/0008-5472.CAN-05-2502 (Pubitemid 43166032)
105. Balazovich K. J., Fernandez R., Hinkovska-Galcheva V., Suchard S. J., Boxer L. A., Transforming growth factor- β 1 stimulates degranulation and oxidant release by adherent human neutrophils. Journal of Leukocyte Biology 1996 60 6 772 777 2-s2.0-0030467925 (Pubitemid 27041667)
106. De Larco J. E., Wuertz B. R. K., Furcht L. T., The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8. Clinical Cancer Research 2004 10 15 4895 4900 2-s2.0-4143050218 10.1158/1078-0432.CCR-03-0760 (Pubitemid 39099762)
107. López-Otín C., Palavalli L. H., Samuels Y., Protective roles of matrix metalloproteinases: from mouse models to human cancer. Cell Cycle 2009 8 22 3657 3662 2-s2.0-70449971114 10.4161/cc.8.22.9956
108. Balbín M., Fueyo A., Tester A. M., Pendás A. M., Pitiot A. S., Astudillo A., Overall C. M., Shapiro S. D., López-Otín C., Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nature Genetics 2003 35 3 252 257 2-s2.0-0242361314 10.1038/ng1249 (Pubitemid 37363179)
109. Palosaari H., Wahlgren J., Larmas M., Rönkä H., Sorsa T., Salo T., Tjäderhane L., The expression of MMP-8 in human odontoblasts and dental pulp cells is down-regulated by TGF- β 1. Journal of Dental Research 2000 79 1 77 84 2-s2.0-0034439008
110. Yang M., Shen H., Qiu C., High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer. European Journal of Cancer 2013 49 3 604 615 10.1016/j.ejca.2012.09.031
111. Zavadil J., Narasimhan M., Blumenberg M., Schneider R. J., Transforming growth factor- β and microRNA:mRNA regulatory networks in epithelial plasticity. Cells Tissues Organs 2007 185 1-3 157 161 2-s2.0-34250770436 10.1159/000101316 (Pubitemid 46956856)
112. Soria-Valles C., Gutiérrez-Fernández A., Guiu M., The anti-metastatic activity of collagenase-2 in breast cancer cells is mediated by a signaling pathway involving decorin and miR-21. Oncogene 2013 10.1038/onc.2013.267
113. Hargadon K. M., Tumor-altered dendritic cell function: implications for anti-tumor immunity. Frontiers in Immunology 2013 4, article 192 10.3389/fimmu.2013.00192
114. Bauer K., Michel S., Reuschenbach M., Nelius N., Von Knebel Doeberitz M., Kloor M., Dendritic cell and macrophage infiltration in microsatellite-unstable and microsatellite-stable colorectal cancer. Familial Cancer 2011 10 3 557 565 2-s2.0-80055014005 10.1007/s10689-011-9449-7
115. Ghiringhelli F., Puig P. E., Roux S., Parcellier A., Schmitt E., Solary E., Kroemer G., Martin F., Chauffert B., Zitvogel L., Tumor cells convert immature myeloid dendritic cells into TGF- β -secreting cells inducing CD4+CD25+ regulatory T cell proliferation. Journal of Experimental Medicine 2005 202 7 919 929 2-s2.0-25844504654 10.1084/jem.20050463 (Pubitemid 41396892)
116. Wrzesinski S. H., Wan Y. Y., Flavell R. A., Transforming growth factor- β and the immune response: implications for anticancer therapy. Clinical Cancer Research 2007 13 18, part 1 5262 5270 2-s2.0-34848857434 10.1158/1078-0432.CCR-07-1157 (Pubitemid 47510349)
117. Geissmann F., Revy P., Regnault A., Lepelletier Y., Dy M., Brousse N., Amigorena S., Hermine O., Durandy A., TGF- β 1 prevents the noncognate maturation of human dendritic Langerhans cells. Journal of Immunology 1999 162 8 4567 4575 2-s2.0-0033561648 (Pubitemid 29314856)
118. Chaux P., Favre N., Bonnotte B., Moutet M., Martin M., Martin F., Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression. A role in the immune tolerance to antigenic tumors. Advances in Experimental Medicine and Biology 1997 417 525 528 2-s2.0-0030766236
119. Kis-Toth K., Bacskai I., Gogolak P., Monocyte-derived dendritic cell subpopulations use different types of matrix metalloproteinases inhibited by GM6001. Immunobiology 2013 218 11 1361 1369 10.1016/j.imbio.2013.06.012
120. Gawden-Bone C., Zhou Z., King E., Prescott A., Watts C., Lucocq J., Dendritic cell podosomes are protrusive and invade the extracellular matrix using metalloproteinase MMP-14. Journal of Cell Science 2010 123, part 9 1427 1437 2-s2.0-77951719523 10.1242/jcs.056515
121. Ribatti D., Mast cells and macrophages exert beneficial and detrimental effects on tumor progression and angiogenesis. Immunology Letters 2013 152 2 83 88 10.1016/j.imlet.2013.05.003
122. Ribatti D., Crivellato E., The controversial role of mast cells in tumor growth. International Review of Cell and Molecular Biology 2009 275 C 89 131 2-s2.0-66149120295 10.1016/S1937-6448(09)75004-X
123. Gruber B. L., Marchese M. J., Kew R. R., Transforming growth factor- β 1 mediates mast cell chemotaxis. Journal of Immunology 1994 152 12 5860 5867 2-s2.0-0028181253
124. Dyduch G., Kaczmarczyk K., Okoń K., Mast cells and cancer: enemies or allies? Polish Journal of Pathology 2012 63 1 1 7 2-s2.0-84860142714
125. Ribatti D., Crivellato E., Mast cells, angiogenesis and cancer. Advances in Experimental Medicine and Biology 2011 716 270 288 2-s2.0-79960896329 10.1007/978-1-4419-9533-9-14
126. Ganeshan K., Bryce P. J., Regulatory T cells enhance mast cell production of IL-6 via surface-bound TGF- β Journal of Immunology 2012 188 2 594 603 2-s2.0-84856002777 10.4049/jimmunol.1102389
127. Chung A. S., Wu X., Zhuang G., An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy. Nature Medicine 2013 19 1114 1123 10.1038/nm.3291
128. Chen W. C., Lai Y. H., Chen H. Y., Interleukin-17-producing cell infiltration in the breast cancer tumor microenvironment is a poor prognostic factor. Histopathology 2013 63 2 225 233
129. Nam J.-S., Terabe M., Kang M.-J., Chae H., Voong N., Yang Y.-A., Laurence A., Michalowska A., Mamura M., Lonning S., Berzofsky J. A., Wakefield L. M., Transforming growth factor β subverts the immune system into directly promoting tumor growth through interleukin-17. Cancer Research 2008 68 10 3915 3923 2-s2.0-45549088943 10.1158/0008-5472.CAN-08-0206
130. Numasaki M., Fukushi J.-I., Ono M., Narula S. K., Zavodny P. J., Kudo T., Robbins P. D., Tahara H., Lotze M. T., Interleukin-17 promotes angiogenesis and tumor growth. Blood 2003 101 7 2620 2627 2-s2.0-0037849915 10.1182/blood-2002- 05-1461 (Pubitemid 36857622)
131. Coussens L. M., Raymond W. W., Bergers G., Laig-Webster M., Behrendtsen O., Werb Z., Caughey G. H., Hanahan D., Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes and Development 1999 13 11 1382 1397 2-s2.0-0033151608 (Pubitemid 29270244)
132. Coussens L. M., Tinkle C. L., Hanahan D., Werb Z., MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 2000 103 3 481 490 2-s2.0-0034721666
133. Roche W. R., The nature and significance of tumour-associated mast cells. Journal of Pathology 1986 148 2 175 182 2-s2.0-0022591389 (Pubitemid 16111186)
134. Fang K. C., Wolters P. J., Steinhoff M., Bidgol A., Blount J. L., Caughey G. H., Mast cell expression of gelatinases A and B is regulated by kit ligand and TGF- β Journal of Immunology 1999 162 9 5528 5535 2-s2.0-0033136337 (Pubitemid 29307165)
135. Gruber B. L., Marchese M. J., Suzuki K., Schwartz L. B., Okada Y., Nagase H., Ramamurthy N. S., Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation. Journal of Clinical Investigation 1989 84 5 1657 1662 2-s2.0-0024429920 (Pubitemid 19272256)
136. Dufour A., Overall CM missing the target: matrix metalloproteinase antitargets in inflammation and cancer. Trends in Pharmacological Sciences 2013 34 4 233 242 10.1016/j.tips.2013.02.004
137. Zhang W., Zhu X.-D., Sun H.-C., Xiong Y.-Q., Zhuang P.-Y., Xu H.-X., Kong
138. Vukanovic J., Isaacs J. T., Linomide inhibits angiogenesis, growth, metastasis, and macrophage infiltration within rat prostatic cancers. Cancer Research 1995 55 7 1499 1504 2-s2.0-0028937723
139. Zhu S., Niu M., 'Mary H. O., Cui Z., Targeting of tumor-associated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles. Molecular Pharmaceutics 2013 10 9 3525 3530 10.1021/mp400216r